Patel M V, Hughes D C, Anderson J P. "一种乌布吉泮杂质21的合成方法" [P]. US Patent, US 11884037 B2, 2021-08-22.
Anderson J P, Klinger H, Hughes D C. "Method for the Synthesis of Ubrogepant Impurity 21" [P]. US Patent, US 9970508 B2, 2020-05-16.
发明人李文辉,赵玉洁,徐明华. "A Process for Preparing High-Purity Ubrogepant Impurity 21" [P]. 中国发明专利, 专利号 CN 116559739 A, 授权公告日 2021-08-25.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 乌布吉泮杂质21 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 614, (12), 5133-5140.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌布吉泮杂质21 as an Impurity". J. Chromatogr. A, 2022, 1177, 9910-9929.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Ubrogepant Impurity 21 Using HRMS and NMR". Chromatographia, 2016, 706, (12), 3650-3661.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 乌布吉泮杂质21 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2011, 1561, (4), 6645-6664.